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Abstract
Background: Threatened miscarriage involves vaginal bleeding in a pregnancy that remains viable. This is a
common early pregnancy complication with increased risk factors for early pregnancy loss, preterm premature
rupture of membranes (PPROM), preterm delivery, low birth weight babies and maternal antepartum haemorrhage.
Currently there are no recommended medical treatment options, rather women receive advice that centres on a
‘wait and see’ approach. For women with a history of unexplained recurrent miscarriage providing supportive care
in a subsequent pregnancy improves live birthing outcomes, but the provision of supportive care to women
experiencing threatened miscarriage has to date not been examined.
Discussion: While it is known that 50-70% of miscarriages occur due to chromosomal abnormalities, the potential
for therapeutic intervention amongst the remaining percentage of women remains unknown. Complementary and
alternative medicine (CAM) therapies have the potential to provide supportive care for women presenting with
threatened miscarriage. Within fertility research, acupuncture demonstrates beneficial hormonal responses with
decreased miscarriage rates, raising the possibility acupuncture may promote specific beneficial effects in early
pregnancy. With the lack of current medical options for women presenting with threatened miscarriage it is timely
to examine the possible treatment benefits of providing CAM therapies such as acupuncture.
Summary: Despite vaginal bleeding being a common complication of early pregnancy there is often reluctance
from practitioners to discuss with women and medical personal how and why CAM may be beneficial. In this
debate article, the physiological processes of early pregnancy together with the concept of providing supportive
care and acupuncture are examined. The aim is to raise awareness and promote discussion as to the beneficial role
CAM may have for women presenting with threatened miscarriage.
Background
Vaginal bleeding is a common complication of preg-
nancy, with an estimated 20% of pregnant women
experiencing this in the first 12 weeks of their preg-
nancy [1]. Threatened miscarriage involves vaginal
bleeding with a viable fetus under 20 weeks gestation
and a cervix that remains closed [2]. While a pregnancy
can be established through ultrasound diagnostics
detecting the presence of an interuturine gestational
sack, it is recommended that diagnosis of threatened
miscarriage viability be determined by the presence of a
fetal heart beat [3]. While the risk of subsequent preg-
nancy loss is reduced following this confirmation of
cardiac activity, these pregnancies remain at risk.
Women presenting with light vaginal bleeding have
twice the rate of miscarriage when compared to preg-
nancies with no vaginal bleeding, with this risk factor
increasing to four times with heavy vaginal bleeding [4].
Women presenting with threatened miscarriage may
also remain at risk for adverse pregnancy outcomes
until delivery at term. These pregnancies are associated
with events such as antepartum haemorrhage, premature
delivery, and result in a significantly higher rate of low-
birthweight babies [3,5]. Women presenting with threa-
tened miscarriage also have twice the risk of delivering
prematurely between 34 to 37 weeks [6], with risk the
factors associated with birth before 37 weeks gestation
including neonatal death [7]. * Correspondence: 16910687@student.uws.edu.au
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Currently the clinical treatment for women presenting
with a threatened miscarriage involves a “wait and see”
approach. While a Cochrane systematic review found
evidence of reduced miscarriage rates for women using
progesterone supplementation (risk ratio (RR) 0.53; 95%
confidence interval (CI) 0.35-0.79), the authors con-
cluded that due to the small number of participants
(421) and the poor methodological quality of eligible
studies (four) there was insufficient evidence at present
to support the routine use of progestogens for the treat-
ment of threatened miscarriage. It was recommended
that further randomised controlled trials were required
to examine the safety of using this treatment during
early pregnancy [8]. In a Cochrane review of anti coagu-
lant therapies [9], the use of unfractionated heparin and
low dose aspirin was found to be beneficial in women
with antiphospholipid antibodies and recurrent preg-
nancy loss, however the benefits of using this therapy in
women with antiphospholipid antibodies without a his-
tory of recurrent miscarriage was not thought to be suf-
ficient to recommend its use. In this review caution was
also advised for the use of prednisone for all pregnant
women with adverse effects including premature deliv-
ery and gestational diabetes. Bed rest has also been
examined as a treatment intervention, with a Cochrane
systematic review examining two small studies involving
a total number of 84 women. No statistically significant
difference was found for the risk of miscarriage in the
bed rest group (hospital or home), versus a no bed rest
group (placebo or other treatment). (RR)1.54, 95% confi-
dence interval (CI) 0.92 to 2.58), leading the authors to
conclude that there was not enough information to
recommend bed rest as a treatment option [10].
There are clinical guidelines for establishing fetal via-
bility and treatment options for women experiencing a
miscarriage but currently no clinical guidelines for treat-
ment options that can be offered to women for threa-
tened miscarriage [11,12]. Women who present at Early
Pregnancy Assessment units or to a hospital depart-
ment, GP or midwife with vaginal bleeding and are sub-
sequently confirmed to have a viable pregnancy through
ultrasound receive advice that focuses on the role of
chromosomal abnormalities in miscarriage and that they
can do little but “hope for the best.” The present medi-
cal recommendation is to wait until a woman has
experienced three concurrent miscarriages, before a
diagnosis of recurrent miscarriage is made and investi-
gations undertaken to identify possible causative factors
[13]. The causative factors for pregnancy loss include:
parental chromosomal anomalies, maternal thrombophi-
liac disorders, endocrine disorders, autoimmune condi-
tions, and structural uterine anomalies, but for up to
50% of women a causative factor for their repeated
pregnancy loss is never found [14,15]. While some clini-
cians may begin investigations following two miscar-
riages, rather than waiting for a third to occur, there
remains an acceptance that miscarriage is an acceptable
part of a woman’s reproductive health history. In view
of women delaying childbearing [16], rising maternal
age associations with an increased miscarriage risk [17]
and the negative psychological aspects that occur with
miscarriage [18], it is relevant that potential treatment
options are explored for women presenting with a threa-
tened miscarriage. While accepting that the major cau-
sative factor for miscarriage is non recurring
chromosomal abnormalities, reported as being responsi-
ble for 50-70% of all miscarriages [19] and that causative
factors such as; smoking, pre-existing medical condi-
tions, infectious agents, environmental pollutants or
uterine abnormalities contribute to miscarriage rates,
the reality is that the causative factor for the majority of
miscarriages remains unknown [20,21]. Amongst this
group of women where the cause of miscarriage is
unknown there exists the potential for therapeutic
intervention.
Supportive care as an evidence based treatment option
for recurrent miscarriage
Supportive care has been provided as a specific interven-
tion for women experiencing recurrent miscarriage but
not as yet for women experiencing threatened miscar-
riage. There are various interventions described when
using ‘supportive care’ in studies involving pregnant
women. In a Cochrane systematic review of support
provided during at risk pregnancies, support was defined
as any of the following; emotional (which could include
counseling and reassurance), providing information or
advice, as well as practical support (an example was
given of transportation to clinic appointments) [22].
When supportive care was provided for women with
recurrent miscarriage this care had beneficial outcomes
with research demonstrating increased live births for
woman when compared to a control group receiving
standard antenatal care (Table 1). Of the four studies,
three were controlled trials, two demonstrating a live
birth rate of 86% compared to 33% for women receiving
standard antenatal care, (p < 0.05) [23,24]. With the
third reporting a 26% miscarriage rate in the interven-
tion group compared to 51% in the control group (p <
0.002) [15]. The fourth study was a prospective cohort
study and reported a 75% pregnancy rate beyond 24
gestational weeks [14].
These women were all presenting with a pregnancy
following three or more miscarriages and had underta-
ken previous medical investigations where no cause had
been found for their previous pregnancy losses. The
support provided for these women was not specifically
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cles that referred to antenatal counseling, emotional
support, psychological support, supportive care, tender
loving care (TLC) and health advice. The specific inter-
ventions ranged from a medical investigation - that of a
weekly ultrasound, to care that included advice on stress
reduction, issuing women with a relaxation tape for
home use, and advice about bed rest and abstaining
from sexual intercourse. The specific support detailed
within these research papers is outlined in Table 1.
When women with unexplained recurrent miscarriage
were interviewed about the supportive care they would
prefer to receive in a subsequent pregnancy [25], their
responses included both medical and non medical sup-
port. Women saw medical supportive care as including;
the planning of consultations and ultrasounds with their
gynaecologist, ßHCG blood monitoring prior to their
first ultrasound to determine fetal viability, frequent
(weekly or fortnightly) ultrasounds and a preference to
have only one or two gynaecologists involved in their
care.
They also requested what can be seen as non medical
support; advice about diet and lifestyle activities- includ-
ing the recommendation of trusted websites to obtain
this information, to be asked about their emotional
needs and how they were doing, to be taken seriously,
to feel they were being listened to and understood, to
be offered counseling and relaxation tools, including a
relaxation tape.
Although the studies to date report on the use of sup-
portive care with recurrent miscarriage there is rele-
vancy to threatened miscarriage as in one of these
studies [23] 40% of the women in the supportive care
group experienced symptoms of threatened miscarriage,
often bleeding for several weeks. It was also reported
t h a tw h i l ea na s s u m e dm i s c a r r i a g er a t ei nt h eg e n e r a l
population can be taken as 15%, after accounting for
ectopic pregnancies and testing for genetic abnormal-
ities, only 5% of the miscarriages amongst the women
receiving supportive care remained unexplained. While
chromosomal testing was not available for the control
group and therefore a direct comparison cannot be
made, the miscarriage rate for this group was 67%. The
low rate of unexplained miscarriages and the increased
incidence of successful live birthing outcomes for
women receiving supportive care raise interesting possi-
bilities that this care may have a role to play as a treat-
ment in threatened miscarriage. While the mechanisms
behind why supportive treatment reduces miscarriage
rates remain unknown [15], the suggestion has been
made from two authors, that the provision of regular
medical monitoring and reassurance may reduce stress
for these women which in turn positively impacts on
pregnancy outcomes [23,14]. Despite these studies invol-
ving a small number of women there is acceptance from
the medical community that supportive care is a valid
treatment option. In a review of treatment options for
unexplained recurrent miscarriage the Special Interest
Group Early Pregnancy (SIGEP) of the European Society
for Human Reproduction and Embryology (ESHRE)
recommends supportive care as the only intervention
that does not require further randomized control trials
[26].
Further explanations for why providing reassurance to
women may assist in establishing an optimal environ-
ment for a pregnancy may lie in examining the physiol-
ogy of early pregnancy and the potential of stress to
impact on a pregnancy at this time.
Table 1 Supportive Care use in Recurrent Miscarriage Studies 1984 - 1999
Author Trial design Supportive
care
Control
Group
Supportive care Outcomes
Stray-
Pederson
1984
Non
randomized
controlled trial
N = 37 N = 24 Advice: rest, avoid heavy lifting, travelling, refrain from
sexual intercourse.
Bed rest for 2 weeks at the gestational age they had
previously miscarried.
Reported as live births at term.
Supportive care 32(86%)
Routine antenatal care 8 (33%) (p <
0.001)
Liddell
1991
Randomized
controlled trial
N = 42 (44
pregnancies)
N = 9 A weekly visit (5-13 gestational weeks).
Consistent medical personal, weekly medical
monitoring- (an ultrasound, serum HCG and
progesterone tests), weekly stress reduction session
with a physiotherapist, relaxation tape for home use,
access to visit the early pregnancy clinic for
reassurance.
Reported as live births at term
Supportive care 38 (86%) Routine
antenatal care 3 (33%) (P = 0.005)
Clifford
1997
Non
randomized
controlled trial
N = 160 N = 41 Weekly ultrasound until 12 weeks at a specialized early
pregnancy clinic.
Reported as miscarriage rates 42
(26%) supportive care group 21
women (51%) routine antenatal care
(P = 0.002).
Brigham
1999
Prospective
longitudinal
observational
study
N = 226 N/A Supportive care protocol that included a fortnightly
ultrasound for fetal viability until 12 weeks gestation.
Reported as pregnancy rates. 75%
beyond 24 weeks
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In early pregnancy progesterone levels are dependent on
ovarian production until the placenta takes over produc-
tion at 10-12 weeks [27]. While the immune responses
to implantation and early embryo development are not
fully understood it is thought that immune and inflam-
matory responses capable of destroying the developing
embryo are selectively compromised by progesterone
[28]. It is therefore theoretically possible that a mother’s
response to stress in early pregnancy has a different
effect than in later pregnancy when the placenta has
taken over progesterone production. A suggestion has
been made that stress in ear l yp r e g n a n c ym a yh a v et h e
potential to promote overstimulation of the hypothala-
mic - pituitary - adrenal axis, resulting in decreased pro-
gesterone production, and/or altered immune responses.
This may, in turn, lead to an unfavorable environment
for maintaining a pregnancy [29]. It may be that for
women not miscarrying due to chromosomal abnormal-
ities supportive care can assist women to moderate
stress responses, which in turn may have the potential
to optimise natural hormonal production with beneficial
outcomes. Due to vaginal bleeding being a common
complication of early pregnancy and the lack of medical
care options available, for many women there is a per-
ceived lack of care available to them when they present
with vaginal bleeding and a viable pregnancy. Given that
for many women waiting until they have experienced
several miscarriages before receiving supportive care is
not an acceptable option, it is possible women may seek
complementary therapies as a treatment option rather
than accepting the current medical ‘wait and see
approach.’
As discussed above supportive care has been defined
as providing emotional support and information. Within
recurrent miscarriage research supportive care demon-
strated beneficial pregnancy outcomes in early preg-
nancy. With women with unknown reoccurring
pregnancy loss expressing an interest in receiving infor-
mation on diet and lifestyle, including relaxation techni-
ques, there is the potential for CAM practitioners to
provide emotional support and diet and lifestyle advice,
including relaxation techniques, as supportive care for
women presenting with threatened miscarriage. In addi-
tion to providing supportive care, it is possible that spe-
cific CAM therapies such as acupuncture may have
additional beneficial effects.
The role of acupuncture in the treatment of threatened
miscarriage
Acupuncture is a treatment modality that belongs to the
wider scope of practice within traditional Chinese medi-
cine (TCM), with TCM also including the use of herbal
medical, massage and manipulation techniques.
Acupuncture involves the insertion of needles into spe-
cific body points to stimulate an energetic response
involving qi, also termed energy or the body’s life force.
The aim is to initiate therapeutic responses through
being able to promote the smooth flow of qi within well
defined pathways, known as meridians. The decision as
to which acupuncture points are chosen comes from a
diagnostic framework that considers the persons indivi-
dual characteristics as well as presenting signs and
symptoms. Historically there are texts detailing the use
of acupuncture treatment date from 200 BCE, but these
texts do not specifically address women health issues
until the Song Dynasty, when the writings of scholars
and physicians identified disorders specifically related to
women’s fertility, pregnancy and postpartum [30]. In
particular there was a emphasis on blood production
and movement within women’s bodies that underpinned
diagnosis and treatment, resulting in careful observation
and documentation for uterine bleeding as part of men-
strual cycles, during pregnancy and postpartum.
Sun Simiao (581-682 CE) was an early writer who
stressed the importance of female health for successful
reproduction, with TCM advice both for successfully
maintaining a pregnancy and for treatment when there
was vaginal bleeding in early pregnancy [31].
These historical concepts of treating women for vagi-
nal bleeding in pregnancy, acknowledged as potential
miscarriage, continued to be explored throughout the
development of traditional Chinese medicine, forming
the basis for acupuncture treatment protocols given in
acupuncture text books published today [32-36].
Although these treatment recommendations exist
within text books there is as yet no convincing evidence
based literature that acupuncture is an effective treat-
ment for threatened miscarriage. The only reported
study to date (Table 2) consist of a clinical trial from
within China [37]. Clinical trials from China are often
developed to meet different criteria than clinical trials
involving acupuncture in western medical settings. As
there is often an acceptance that acupuncture is an
effective treatment trials may be undertaken to demon-
strate how, rather than if, they should be used within a
public health system [38]. The study in Table 2 is an
example of this, comparing different styles of acupunc-
ture with no attempt made to evaluate the acupuncture
treatment against a control group. The methodology of
this study is poor with a high risk of bias as outlined in
Table 2 giving no confidence in the reported results.
Although quality research does not yet exist to sup-
port the use of acupuncture for threatened miscarriage,
there is some limited research examining the use of acu-
puncture amongst women experiencing fertility related
issues that may have relevance. This research examines
both how women experience the care they receive and
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responses.
In an attempt to gather information about how infer-
tile women viewed the acupuncture treatment they
received a randomised controlled trial examined the
effectiveness of acupuncture for reducing infertility-
related stress. This involved 32 women receiving acu-
puncture compared with a wait-list control. Women in
the acupuncture group reported significant changes on
a validated questionnaire assessing infertility-related
stress; the Fertility Problem Inventory (FPI), demon-
strating less social concern (mean difference [MD] -
3.75, 95% confidence interval [CI] - 7.58 to 0.84, p =
0.05), and less relationship concern (MD - 3.66, 95%
CI - 6.80 to - 0.052, p = 0.02). In the qualitative arm
of this study women described positive benefits in
terms of feeling relaxed, calm, and gaining a sense of
control [39].
In a small qualitative study exploring the experiences
of women receiving acupuncture treatment to improve
their fertility all eight women interviewed expressed
positive emotional effects specifically relating to treat-
ment. These benefits included their ability to cope with
daily life stress, any medical treatment undertaken and
regaining a sense of personal control and were reported
even when there was no positive pregnancy outcome
[40]. While limited by the small number of participants
this exploratory research suggests that women see acu-
puncture as providing supportive care and beneficial
effects in terms of their ability to cope when confronted
with infertility related issues.
In an attempt to examine physiological responses to
acupuncture treatment, women in a small prospective
study, were tested for hormonal changes while under-
going IVF treatment. The 34 women receiving acupunc-
ture demonstrated significant beneficial changes in
serum cortisol and prolactin levels (stress hormones
thought to impact on IVF pregnancy rates), compared
to the 33 women receiving IVF medication alone [41].
In addition, this study found a significant reduction in
miscarriage rates amongst those women receiving acu-
puncture treatment (p < 0.05). While further studies are
required to confirm this it may be that acupuncture has
potential to promote beneficial hormonal responses in
early pregnancy that would be advantageous to women
presenting with threatened miscarriage.
Discussion
In clinical practice acupuncture can be seen as a com-
plex treatment intervention [42]. Where treatment is
individually formulated by the practitioner in response
to their interpretation of a person’s presentation and
where treatment effects are not only derived from the
use of needles, but also associated interventions such as
diet and lifestyle advice. Non specific components, such
as providing attention, touch, and the development of a
therapeutic supportive relationship are also thought to
contribute to acupuncture treatment effects. As such
these effects can be seen as providing supportive care
and may be practitioner specific.
It remains unclear just how possible it is to tease any
specific needling effects apa r tf r o mt h e s en o ns p e c i f i c
treatment effects. For example, when women receiving
acupuncture from the same practitioner discussed
receiving treatment, benefits were attributed both in
terms of the specific practitioner relationship and speci-
fic needling effects [39].
I found her really easy to talk to in that regard, so that
was good. What I found really positive was talking to
[her] before the treatment; that was really great (S2).
Well it was a very warm fuzzy feeling, very relaxed,
warm, and feeling like it had made a big difference (S5).
It has been argued that due to these difficulties in
determining the ‘active’ components of CAM therapies
such as acupuncture, trials to evaluate treatment effects
should first start with examining safety and effective-
ness. A possibility when using pragmatic randomized
controlled trials. When effectiveness has been estab-
lished further studies can then be undertaken involving
randomised controlled trials with placebo arms to seek
out active treatment components [43].
To further investigate the potential effects of acupunc-
ture therapy on women presenting with threatened mis-
carriage a mixed methods study is currently being
conducted in Wellington New Zealand. In acknowledge-
ment that in the process of providing acupuncture treat-
ment, non specific therapeutic factors contribute to
treatment effects, the randomised controlled trial aspect
Table 2 A Randomised Controlled Trial of Acupuncture use in Threatened Miscarriage
Study Method Participants Intervention Outcomes Risk of Bias
Li &
Xie,
2005
Randomised
controlled
trial
60 women with vaginal
bleeding of less than 24
hours recruited between 5
and 27 gestational weeks
from hospital clinic.
Women allocated to two
treatment groups with each
group receiving a different
style of acupuncture -once a
day for ten days.
Reported as a 90% live birthing
rate in one group compared to
60% (p < 0.01). No attempt to
stratify women for confounding
variables of maternal and
gestation age.
High No details of
Randomization process No
allocation concealment No
blinding of participants or
outcome assessors No
reporting of any incomplete
data or loss to follow up.
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active control group receiving supportive care only. In
the qualitative arm of this study thematic analysis will
be used to examine the experience of receiving both
supportive care and acupuncture. Further details for this
study can be found on the Australian New Zealand
Clinical Trials Registry (ANZCTR), registration number:
ACTRN12610000850077.
There is often reluctance from CAM practitioners to
discuss with women and medical personal how and
when CAM therapies such as acupuncture may be bene-
ficial for women experiencing vaginal bleeding early in
pregnancy. Perhaps this is due to concerns that any
treatment will be associated with a subsequent miscar-
riage but it is also possible that practitioners are not
aware of the role of supportive care as accepted evi-
dence based practice within recurrent miscarriage care.
T h e ym a ya l s ob eu n f a m i l i a rw i t ht h ep h y s i o l o g yo f
early pregnancy and the potential for stress responses to
negatively impact on pregnancy outcomes.
Further research is required to examine any possible
benefits from both the delivery of supportive care for
women presenting with threatened miscarriage and pro-
viding acupuncture at this time. However for practi-
tioners working with women to promote fertility related
issues and pregnancy care it is logical that interested
women presenting with threatened miscarriage are pro-
vided with the information known at present, allowing
them to make informed choices around possible treat-
ment options, rather than being forced to adapt the cur-
rent medical ‘wait and see approach’. It is also logical
that discussions are undertaken with the medical perso-
nal involved in care of these women as to the possible
benefits of CAM therapies involving supportive care and
more specifically acupuncture as providing possible ben-
eficial effects.
Summary
Current evidence recommends that supportive care be
offered to women after they have experienced three or
more miscarriages. Women have requested that this
supportive care include diet and lifestyle advice, includ-
ing trusted internet sites to visit, relaxation tools and a
therapeutic relationship. For women presenting with
threatened miscarriage, it is known that 50-70% women
who miscarry do so due to chromosomal abnormalities,
but it is unknown what percentage of the remaining
women, miscarrying for unidentified reasons, could be
aided by therapeutic interventions such as supportive
care and acupuncture to maintain a successful
pregnancy.
The physiology of early pregnancy raises the possibi-
lity that maternal response to stress may impact negativ-
ity in terms of hormonal responses required to promote
an optimal environment for a pregnancy at risk. CAM
practitioners who offer women emotional support, diet
and lifestyle advice, including relaxation tools, have the
potential to be seen as providing supportive care as part
of their practice and may be ideally placed to assist
women presenting with threatened miscarriage to mod-
erate their stress levels. In addition to offering treatment
women have found to be beneficial in assisting them to
moderate their stress responses acupuncture as a speci-
fic therapy may also have benefits in terms of promoting
specific hormonal responses in early pregnancy. To
further explore possible beneficial outcomes research in
the form of a mixed methods study is currently been
undertaken to examine the effects of acupuncture for
women presenting with threatened miscarriage in Well-
ington New Zealand.
In view of the lack of treatment options women have
when presenting with threatened miscarriage and the
increased risk for subsequent miscarriage, PPROM, pre-
term delivery, low birth weight babies and antepartum
haemorrhage it is relevant to seek possible therapeutic
treatment solutions for this common complication of
early pregnancy. It is hoped that this article will raise
awareness amongst practitioners of CAM as to the med-
ical acceptance of supportive care as a therapeutic treat-
ment and the possible additional benefits of
acupuncture treatment for women presenting with
threatened miscarriage. Enabling practitioners to discuss
the possible benefits of providing care within their prac-
tice both for women seeking treatment and with medical
practitioners involved in their care.
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